STUDY DESIGN: Secondary analysis of a prospective T1 screen cohort study. All ultrasounds were performed by Fetal Medicine Foundation certified personnel. Fetal NB were characterized as "present" or "absent" if ultrasound quality criteria were met, and characterized as "not adequately visualized" (NAV) if quality criteria were not met. Maternal history, demographics ,body mass index (BMI), and paternal demographics were compared across three groups of NB visualization. Statistical analysis was performed with Mann-Whitney U and Kruskal-Wallis Test. Multivariate logistic regression was used to evaluate the primary determinant of inability to identify the NB. ROC curve and Youden's J statistic were used to calculate clinical relevance. RESULTS: In 2173 participants, NB was absent in 25 (1.2%) and NAV in 54 fetuses (2.5%). While patients with absent or NAV NB were predominantly African American (14/25 [56%] and 33/54 [61%], respectively) the overall distribution of maternal and paternal ethnicity was similar across NB visualization categories (Table 1) . Women with NAV NB had a significantly higher BMI (p <.001, Table 1 ). When participants with NAV and absent NB were combined and compared to those with present NB, differences in race distribution reached significance for maternal and paternal race (p <0.05, respectively). Logistic regression identified BMI as the primary determinant of NAV NB (p <0.01), but failed to identify determinants of an absent NB. ROC analysis showed that maternal BMI >35 predicted NAV of the NB with 42% sensitivity and 84% specificity (p ¼ .001). CONCLUSION: In a population with stringent imaging criteria for NB visualization, maternal or paternal factors were not associated with an absent NB, though increased maternal BMI led to inadequate NB visualization. It is possible that failure to distinguish an inadequately visualized NB from an absent NB may be responsible for associations with ethnicity reported in other studies. In patients with BMI >35, a T1 screen scheduled closer to 14 weeks may improve likelihood of successful NB evaluation.
868 Universal echocardiogram for prenatal diagnosis of congenital heart disease: a costeffectiveness analysis OBJECTIVE: Current guidelines recommend a fetal echocardiogram only upon abnormal fetal cardiac findings on ultrasound and in pregnancies with identified risk factors. However, prenatal detection for congenital heart disease (CHD) is estimated to be 30-50%. Identifying CHD in utero results in a higher probability of being delivered at a tertiary care center and better neonatal outcomes. The purpose of this study was to determine whether universal screening for all pregnant women with fetal echocardiogram is cost effective when compared with current guidelines. STUDY DESIGN: A model was created using TreeAge software to compare the outcomes of universal screening for CHD with fetal echocardiogram and ultrasound compared to ultrasound alone. Women in the ultrasound strategy suspected of having a fetus with CHD were further evaluated with echocardiogram. Clinical outcomes included cases of morbid and non morbid CHD detected, intrauterine fetal demise (IUFD), neonatal death and termination. Probabilities, costs, and utilities were obtained from the literature, and a willingness-to-pay (WTP) threshold was set at $100,000 per quality adjusted life year (QALY). Analysis was from the maternal perspective. Sensitivity analyses were performed to determine the robustness of the results. RESULTS: In a theoretical cohort of 100,000 pregnancies, conducting fetal echocardiograms resulted in 382 additional cases of CHD detected, 14 fewer cases of IUFD and 1 fewer case of neonatal morbidity and 77 additional terminated pregnancies (Table 1) . Despite a slight increase in cost, our model demonstrated that adding echocardiogram for screening led to higher QALYs (costeffective) when compared to current practice. Univariate sensitivity analysis showed that the model was no longer cost-effective when the cost of echocardiogram exceeded $980 (Figure 1 
